A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: A cluster RCT

Patient Education and Counseling

Volumn 84, Issue 2, 2011, Pages

  Chan, Evelyn C Y ^a   McFall, Stephanie L ^b   Byrd, Theresa L ^c   Mullen, Patricia Dolan ^d   Volk, Robert J ^d   Ureda, John ^e   Calderon Mora, Jessica ^c   Morales, Pat ^f   Valdes, Adriana ^f   Kay Bartholomew, L ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ESSEX   (United Kingdom)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Insights Consulting INC   (United States)

^f Cancer and Chronic Disease Consortium ^*  (United States)

Author keywords

Hispanics; Informed decision making; Prostate cancer screening; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; COMMUNICATION SKILL; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; EDUCATION PROGRAM; HISPANIC; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT PREFERENCE; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHOOL;

ADULT; AGED; COMMUNITY-BASED PARTICIPATORY RESEARCH; DECISION MAKING; EARLY DETECTION OF CANCER; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HISPANIC AMERICANS; HUMANS; INFORMED CONSENT; INTERVENTION STUDIES; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SOCIOECONOMIC FACTORS; TEXAS;

EID: 79959973875     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2010.07.033     Document Type: Article

References (46)

1. Farwell W.R., Linder J.A., Jha A.K. Trends in prostate-specific antigen testing from 1995 through 2004. Arch Intern Med 2007, 167:2497-2502.
2. Ross L.E., Berkowitz Z., Ekwueme D.U. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 national health interview survey. Cancer Epidem Biomar 2008, 17:636-644.
3. Scales C.D., Antonelli J., Curtis L.H., Schulman K.A., Moul J.W. Prostate-specific antigen screening among young men in the United States. Cancer 2008, 113:1315-1323.
4. Andriole G.L., Grubb R.L., Buys S.S., Chia D., Church T.R., Fouad M.N., et al. Mortality results from a randomized prostate-cancer screening trial. New Engl J Med 2009, 360:1310-1319.
5. Schroder F.H., Hugosson J., Roobol M.J., Tammela T.L.J., Ciatto S., Nelen V., et al. Screening and prostate-cancer mortality in a randomized European study. New Engl J Med 2009, 360:1320-1328.
6. Barry M.J. Screening for prostate cancer-the controversy that refuses to die. New Engl J Med 2009, 360:1351-1354.
7. U.S. Preventive Services Task Force Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 2008, 149:185-191.
8. Wolf A.M.D., Wender R.C., Etzioni R.B., Thompson I.M., D'Amico A.V., Volk R.J., et al. American Society Guideline for the early detection of prostate cancer update 2010. CA: Cancer J Clin 2010, 60:70-98.
9. Coley C.M., Barry M.J., Mulley A.G. Clinical guideline: Part III. Screening for prostate cancer. Ann Intern Med 1997, 126:480-484.
10. American Urological Association. Prostate-specific antigen best practice statement: 2009 update. Available from: URL http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/psa09.pdf.
11. Lim L.S., Sherin K. Screening for prostate cancer in U.S. men. ACPM position statement on preventive practice. Am J Prev Med 2008, 34:164-170. ACPM Prevention Practice Committee.
12. Volk R.J., Hawley S.T., Kneuper S., Holden E.W., Stroud L.A., Cooper C.P., et al. Trials of decision aids for prostate cancer screening: a systematic review. Am J Prev Med 2007, 33:428-434.
13. Driscoll D.L., Rupert D.J., Golin C.E., McCormack L.A., Sheridan S.L., Welch B.M., et al. Promoting prostate-specific antigen informed decision making. Evaluating two community-level interventions. Am J Prev Med 2008, 35:87-94.
14. Gattellari M., Ward J.E. A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Patient Educ Couns 2005, 57:168-182.
15. Guerra C.E., Jacobs S.E., Holmes J.H., Shea J.A. Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study. J Gen Intern Med 2007, 22:901-907.
16. Hoffman R.M., Helitzer D.L. Moving towards shared decision making in prostate cancer screening. J Gen Intern Med 2007, 22:1056-1057.
17. American Cancer Society Cancer facts & figures for Hispanics/Latinos, 2006-2008 2008, American Cancer Society, Atlanta, GA.
18. McFall SL Use and awareness of prostate specific antigen tests and race/ethnicity. J Urol 2007, 177:1475-1480.
19. McFall S.L. U.S. men discussing prostate-specific antigen tests with a physician. Ann Family Med 2006, 4:433-436.
20. Byrd T., Law J.G. Cross-border utilization of health care services by U.S. residents near the Mexican border. Pan Am J Public Health 2009, 26:95-100.
21. Volk R.J., Cantor S.B., Cass A.R., Spann S.J., Weller S.C., Krahn M.D. Preferences of husbands and wives for outcomes of prostate cancer screening and treatment. J Gen Intern Med 2004, 19:339-348.
22. McFall S.L., Ureda J., Byrd T.L., Valdes A., Morales P., Scott D.B., et al. What is needed for informed decisions about prostate cancer screening: perspectives of African American and Hispanic men. Health Educ Res 2009, 24:280-291.
23. Campbell M.K., Elbourne D.R., Altman D.G. CONSORT statement: extension to cluster randomised trials. Brit Med J 2004, 328:702-708.
24. Cantor S.B., Byrd T.L., Groff J.Y., Reyes Y., Tortolero-Luna G., Mullen P.D. The language translation process in survey research: a cost analysis. Hispanic J Behav Sci 2005, 27:364-370.
25. Radosevich D.M., Partin M.R., Nugent S., Nelson D., Flood A.B., Holtzman J., et al. Measuring patient knowledge of the risks and benefits of prostate cancer screening. Patient Educ Couns 2004, 54:143-152.
26. Chan E.C.Y., Vernon S.W., O'Donnell F.T., Ahn C., Greisinger A., Aga D.W. Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?. Am J Public Health 2003, 93:779-785.
27. Davison B.J., Degner L.F., Morgan T.R. Information and decision-making preferences of men with prostate cancer. Oncol Nurs Forum 1995, 22:1401-1408.
28. Degner L.F., Sloan J.A. Decision making during serious illness: what role do patients really want to play?. J Clin Epidemiol 1992, 45:941-950.
29. Degner L.F., Sloan J.A., Venkatesh P. The Control Preferences Scale. Can J Nurs Res 1997, 29:21-43.
30. Davison B.J., Kirk P., Degner L.F., Hassard T.H. Information and patient participation in screening for prostate cancer. Patient Educ Couns 1999, 37:255-263.
31. Frosch D.L., Kaplan R.M., Felitti V. The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med 2001, 16:391-398.
32. Gattellari M., Ward J.E. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial. J Med Screen 2003, 10:27-39.
33. Wilkins E.G., Lowery J.C., Hamill J.B. The impact of shared decision-making in prostate specific antigen (PSA) screening. Med Decis Making 1996, 19:525.
34. Ruthman J.L., Ferrans C.E. Efficacy of a video for teaching patients about prostate cancer screening and treatment. Am J Health Promot 2004, 18:292-295.
35. Ottawa Decision Support Framework. Evaluation measures. Decisional Conflict Scale. Available from: URL: http://decisionaid.ohri.ca/eval.html%23DecisionalConflictScale.
36. O'Connor A.M. Validation of a decisional conflict scale. Med Decis Making 1995, 15:25-30.
37. Patient Decision Aids Evaluation measures [homepage on the internet]. Patient decision aids 2009, Available from: URL:. http://decisionaid.ohri.ca/eval.html.
38. Murray D.M., Hannan P.J., Wolfinger R.D., Baker W.L., Dwyer J.H. Analysis of data from group-randomized trials with repeat observations on the same groups. Stat Med 1998, 17:1581-1600.
39. Murray D.M., Varnell S.P., Blitstein J.L. Design and analysis of group-randomized trials: a review of recent methodological developments. Am J Public Health 2004, 94:423-432.
40. Ureda JR, Byrd TL, Calderon-Mora JA, Casillas ME, Williams DG, Scott DB. The Use of Illustrated Story Mapping to Enhance Focus Group Discussion. Health Promotion Practice. Pre-published July 16, 2009, doi:10.1177/1524839909341027.
41. Wallerstein N.B., Duran B. Using community-based participatory research to address health disparities. Health Promot Pract 2006, 7:312-323.
42. McFall S.L., Hamm R.M., Volk R.J. Exploring beliefs about prostate cancer and early detection in men and women of three ethnic groups. Patient Educ Couns 2006, 61:109-116.
43. Deibert C.M., Maliski S., Kwan L., Fink A., Connor S.E., Litwin M.S. Prostate cancer knowledge among low income minority men. J Urol 2007, 177:1851-1855.
44. Volk R.J., Jibaja-Weiss M.L., Hawley S.T., Kneuper S., Spann S.J., Miles B.J., et al. Entertainment education for prostate cancer screening: a randomized trial among primary care patients with low health literacy. Patient Educ Couns 2008, 73:482-489.
45. Han P.K., Coates R.J., Uhler R.J., Breen N. Decision making in prostate-specific antigen screening national health interview survey, 2000. Am J Prev Med 2006, 30:394-404.
46. O'Connor A.M., Bennett C.L., Stacey D., Barry M., Col N.F., Eden K.B., et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2009, Art. No.: CD001431, doi:10.1002/14651858.CD001431.pub2.[3], John Wiley & Sons, Ltd.